Trial Profile
An open-label, uncontrolled long-term safety study of CP-464 005 (inhaled insulin) in Japanese patients with type 1 or type 2 diabetes.
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 22 Oct 2009
Price :
$35
*
At a glance
- Drugs Insulin (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- Sponsors Pfizer
- 28 Aug 2008 Planned end date changed from 1 Jan 2009 to 1 Jul 2008 as reported by ClinicalTrials.gov.
- 28 Aug 2008 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 29 Feb 2008 Status changed from initiated to in progress, reported by ClinicalTrials.gov.